The prognostic value of the chemotherapy response score (CRS) varies according to HRD status and the use of maintenance PARP inhibitors in HGSC

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Maria Teresa Dawid de Vera, Marta Arnáez De La Cruz, Iria Rey Ferreira, Manel Montesinos Albert, Beatriz Montero Balaguer, Pablo Padilla-Iserte, Luis Matute Tobías, Santiago Domingo Del Pozo, Victor Lago Leal
DOI: 10.1016/j.ijgc.2025.103812
Cited by: 0

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment PARP inhibition in cancer therapy BRCA gene mutations in cancer

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103812–103812
Publication date
1 February 2026
Language
EN